Answers are grounded in this paper and cite their sources.
Background Reactivation of BK polyomavirus (BKPyV) in kidney transplant recipients can lead to BKPyV-associated nephropathy (BKPyVAN), a major cause of allograft dysfunction. Quantitative nucleic acid amplification tests (QNATs) enable monitoring, yet inter-assay variability may complicate interpretation despite calibration to the WHO International Standard. Objective This study compared the qualitative agreement, quantitative correlation, and agreement across predefined viral-load strata among three automated assays: Alinity m BKV, cobas BKV, and Panther Fusion BKV. Methods Remnant EDTA plasma specimens (n = 160) from kidney transplant recipients were tested on Alinity m BKV and cobas BKV (n = 160 each) and on Panther Fusion BKV (n = 152). Pairwise analyses included qualitative agreement, Cohen’s κ , Deming regression, Bland-Altman bias and agreement across viral-load strata (≤ 4 and > 4 log 10 IU/mL). Results Overall qualitative agreement ranged from 92.1% to 96.1%, with κ indicating substantial to near-perfect agreement. Quantitative correlations were strong (r ≥ 0.929), with minimal mean bias (-0.33 to -0.08 log 10 IU/mL). Agreement was higher at ≤ 4 log 10 IU/mL and moderate at > 4 log 10 IU/mL. Discordances clustered near assay limits of quantification. Conclusion The three automated assays showed high qualitative agreement and closely aligned quantitative results, with minor systematic differences near the quantification limit. Because these commercial assays report IU/mL while historical guideline thresholds are in copies/mL, clinical decisions are best supported by assay-consistent longitudinal trends rather than cross-platform threshold comparisons.
No takes yet. Share an insight, caveat, or question.
Gooey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: